跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Celldemic Pre-pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free - TGA Drug Approval Details
Approvals
/
TGA
/
Celldemic Pre-pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free
Approved
STANDARD
Celldemic Pre-pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free
Seqirus Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
64a134da960a8638
Company
Seqirus Pty Ltd
Type
Standard
Approval Details
Approval Id
64a134da960a8638
Product Name
Celldemic Pre-pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free
Artg Id
446673
Artg Name
CELLDEMIC Pre-pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free
Sponsor
Seqirus Pty Ltd
Company Detail Path
/organization/seqirus-pty-ltd
Artg Date
2025-06-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
64a134da960a8638
Type
Standard
Back to TGA Approvals